SCHEMBL8317339

SCHEMBL8317339

[c]1sccc1OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
CYP2C19 P33261 1/20 0.41
PTGS2 P35354 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HIF1A Q16665 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MAOB P27338 6/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40
MAOA P21397 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4911788 0.81 MAOB (0.43) PTGS1PTGS2MAOBMAOARAB9A
SCHEMBL5757555 0.76 PDK1 (0.30)
SCHEMBL5759560 0.75 SMN1; SMN2 (0.43) LMNACYP1A2MAPTTDP1RAB9A
SCHEMBL3058689 0.71 MAPT (0.50) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL95381 0.68 TSHR (0.44) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL2090546 0.67 ALOX5 (0.53) LMNACYP1A2PTGS1SLC6A2CYP2C19
SCHEMBL29366230 0.66 TSHR (0.52) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL756581 0.66 TSHR (0.52) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL11375320 0.65 TSHR (0.41) TSHRLMNACYP1A2PTGS1SLC6A2
SCHEMBL11258306 0.65 TSHR (0.41) TSHRLMNACYP1A2PTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5968948-A FOR TREATMENT OF EPILEPSY, STROKE, ALZHEIMER'S DISEASE, BRAIN DISEASES OR AS ANTIINFLAMMATORY OR ANTIPROLIFERATIVE AGENTS BOERHINGER INGELHEIM GMBH (DE) 1999-10-19 US disclosed
EP-0934940-A1 CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF Japan Tobacco Inc. (JP) 1999-08-11 EP disclosed
US-5807850-A Therapeutic agent for osteoporosis and triazepine compound JAPAN TOBACCO, INC. (JP) 1998-09-15 US disclosed
EP-0792880-A1 OSTEOPOROSIS REMEDY AND TRIAZEPINE COMPOUND Japan Tobacco Inc. (JP) 1997-09-03 EP disclosed
US-5661157-A Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations BOEHRINGER INGELHEIM KG (DE) 1997-08-26 US disclosed